Search

Your search keyword '"Cross, Simon S."' showing total 142 results

Search Constraints

Start Over You searched for: Author "Cross, Simon S." Remove constraint Author: "Cross, Simon S." Topic female Remove constraint Topic: female
142 results on '"Cross, Simon S."'

Search Results

1. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

2. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

3. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

4. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

5. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

6. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

7. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

8. Rare germline copy number variants (CNVs) and breast cancer risk

9. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

10. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

11. Genetic insights into biological mechanisms governing human ovarian ageing

12. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

13. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumBreast Cancer Risk Factors and Survival By Tumor Subtype

14. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

15. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

16. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

17. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

18. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

19. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

20. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

21. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

22. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

23. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

24. Genome-wide association study of germline variants and breast cancer-specific mortality.

25. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

26. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

27. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

28. Association analysis identifies 65 new breast cancer risk loci

29. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

30. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

31. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

32. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

33. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

34. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

35. Age- and Tumor Subtype–Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

36. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

37. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

38. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

39. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

40. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

41. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

42. RAD51B in Familial Breast Cancer.

43. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

44. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

45. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

46. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

47. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

48. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

49. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

50. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.

Catalog

Books, media, physical & digital resources